Traffic Light: Prognosis-based eligibility for clinical trials of hematopoietic SCT in adults with sickle cell anemia

Bone Marrow Transplantation

Volumn 50, Issue 7, 2015, Pages 918-923

  Rotz, S J ^a,b   O'Riordan, M A ^b   Kim, C ^a   De Lima, M ^a   Gladwin, M T ^c   Little, J A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); DEMOGRAPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LABORATORY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RISK ASSESSMENT; SEPSIS; SICKLE CELL ANEMIA; TRANSFUSION; UNITED KINGDOM; UNITED STATES; ADOLESCENT; ANEMIA, SICKLE CELL; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84934841971     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.11     Document Type: Article

References (38)

1. Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol 1996; 13: 501-512.
2. Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT III. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med 1984; 311: 780-783.
3. Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110: 2749-2756.
4. Hsieh M, Courtney F, Weitzel RP, Link M, Wynona C, Xiongce Z et al. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA 2014; 312: 48-56.
5. Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009; 361: 2309-2317.
6. Walters M, Patience M, Leisenring W, Eckman J, Buchanan G, Rogers Z et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996; 2: 100-104.
7. Bolanõs-Meade J, Fuchs EJ, Luznik L, Lanzkron SM, Gamper CJ, Jones RJ et al. HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 2012; 120: 4285-4291.
8. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood 2010; 115: 3447-3452.
9. Abboud MR. Hematopoietic stem-cell transplantation for adults with sickle cell disease. N Engl J Med 2009; 361: 2380-2381.
10. Angelucci E, Matthes-Martin S, Baronciani D, Bernaudin F, Bonanomi S, Cappellini MD et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica 2014; 99: 811-820.
11. Shenoy S. Has stem cell transplantation come of age in the treatment of sickle cell disease? Bone Marrow Transplant 2007; 40: 813-821.
12. Hsieh MM, Fitzhugh CD, Tisdale JF. Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood 2011; 118: 1197-1207.
13. Krishnamurti L. Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease (STRIDE) (Internet). 2014 (cited 10 May 2013). Available from: http://clinicaltrials.gov/ct2/show/record/NCT01565616.
14. Machado RF, Barst RJ, Yovetich NA, Hassell KL, Kato GJ, Gordeuk VR et al. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood 2011; 118: 855-864.
15. Gladwin MT, Barst RJ, Gibbs JSR, Hildesheim M, Sachdev V, Nouraie M et al. Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PLoS One 2014; 9: e99489.
16. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH et al. Mortality in sickle cell disease-life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
17. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-895.
18. Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol 2006; 134: 109-115.
19. De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol 2008; 83: 19-25.
20. Machado RF, Anthi A, Steinberg MH, Bonds D, Sachdev V, Kato GJ et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 2006; 296: 310-318.
21. Machado RF, Hildesheim M, Mendelsohn L, Remaley AT, Kato GJ, Gladwin MT. NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease. Br J Haematol 2011; 154: 512-520.
22. Kato GJ, McGowan V, Machado RF, Little JA, Taylor J, Morris CR et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006; 107: 2279-2285.
23. Ayyappan S, Drawz P, Nouraie M, Hildesheim ME, Zhang Y, Gordeuk VR et al. Renal disease in sickle cell: clinically varied and associated with increased mortality. Blood (ASH Annual Meeting Abstracts) 2012; 120: 90.
24. Ballas SK. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol 2001, p 30-36.
25. Sebastiani P, Nolan VG, Baldwin CT, Abad-Grau MM, Wang L, Adewoye AH et al. A network model to predict the risk of death in sickle cell disease. Blood 2007; 110: 2727-2735.
26. Gardner K, Suddle A, Kane P, O'Grady J, Heaton N, Bomford A et al. How we treat sickle hepatopathy and liver transplantation in adults. Blood 2014; 123: 2302-2307.
27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470.
28. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med 2008; 359: 2254-2265.
29. Sebastiani P. On line calculator of severity of sickle cell disease (Internet) (cited 30 Jan 2012). Available from: http://www.bu.edu/sicklecell/projects/.
30. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22: 1-6.
31. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 2000; 95: 1918-1924.
32. Van Besien K, Koshy M, Anderson-Shaw L, Talishy N, Dorn L, Devine S et al. Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions. Bone marrow transplant 2001; 28: 545-549.
33. Kodish E, Lantos J, Stocking C, Singer PA, Siegler M, Johnson FL. Bone marrow transplantation for sickle cell disease: a study of parents' decisions. N Engl J Med 1991; 325: 1349-1353.
34. Chakrabarti S, Bareford D. A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant 2007; 39: 447-451.
35. Zhang M-J, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M. Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2012; 18: 1204-1210.
36. Shenoy S, Grossman W, DiPersio J, Yu L, Wilson D, Barnes Y et al. A novel reducedintensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2005; 35: 345-352.
37. Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 2011; 17: 1375-1382.
38. Naik RP, Streiff MB, Haywood C Jr, Nelson JA, Lanzkron S. Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. Am J Med 2013; 126: 443-449